Zhang Pei, Bai Xing-Hua, Huang Xue, Li Xin, Pan Wei-Bing, Xu Zhe
School of Acupuncture- Moxibustion and Tuina, Beijing University of CM, Beijing 100029, China.
Forth Medicine Center of the General Military Hospital.
Zhongguo Zhen Jiu. 2020 May 12;40(5):488-92. doi: 10.13703/j.0255-2930.20191112-k0001.
To compare the clinical effect on gastroesophageal reflux asthma between the needling technique of acupuncture (acupuncture for promoting the circulation of the governor vessel and reducing the reversed ) and omeprazole enteric capsules (OME).
A total of 60 patients with gastroesophageal reflux asthma were randomized into an acupuncture group and a western medication group, 30 cases in each one. The basic treatment for anti-bronchial asthma was provided in both of the groups. Additionally, OME was prescribed for oral administration in the western medication group, twice a day, 20 mg each time, for 8 weeks. In the acupuncture group, the needling technique of acupuncture was added. The needles were inserted at the sites inferior to the spinous processes of T to T. Acupuncture was given once in the morning on Tuesday, Thursday and Saturday respectively, totally for 8 weeks. Separately, before and after treatment, the score of reflux disease diagnostic questionnaire (RDQ), the score of asthma control test (ACT) and the tenderness threshold at the sites inferior to the spinous processes of T to T were observed and the clinical effect was evaluated in the two groups.
①The remarkably effective and curative rate was 46.7% (14/30) in the acupuncture group, higher than 3.3% (1/30) in the western medication group (<0.01). The asthma control rate was 66.7% (20/30) in the acupuncture group, higher than 13.3% (4/30) in the western medication group (<0.01). ②RDQ score after treatment was lower than that before treatment in either group (<0.05). The decrease range of RDQ score in the acupuncture group was larger than that of the western medication group (<0.05). After treatment, ACT score was increased as compared with that before treatment in either group (<0.05) and the increase range of ACT score in the acupuncture group was larger than that of the western medication group (<0.05). ③The tenderness thresholds at the sites inferior to the spinous processes of T to T and T to T were all increased after treatment as compared with those before treatment in the acupuncture group separately (<0.05). In the western medication group, the thresholds were only increased at the sites inferior to the spinous processes of T, T and T after treatment as compared with those before treatment separately (<0.05). After treatment, the tenderness thresholds at T to T in the acupuncture group were all higher than the western medication group (<0.05).
The needling technique of acupuncture effectively relieves the symptoms of gastroesophageal reflux asthma and improves the quality of life in the patients and its effect is better than omeprazole enteric capsules.
比较针刺通督降逆针法与奥美拉唑肠溶胶囊(OME)治疗胃食管反流性哮喘的临床疗效。
将60例胃食管反流性哮喘患者随机分为针刺组和西药组,每组30例。两组均给予抗支气管哮喘基础治疗。西药组加用OME口服,每日2次,每次20mg,疗程8周。针刺组在基础治疗上加用通督降逆针法,于T至T棘突下针刺,每周二、周四、周六上午各针刺1次,疗程8周。分别观察两组治疗前后反流性疾病诊断问卷(RDQ)评分、哮喘控制测试(ACT)评分及T至T棘突下压痛阈值,并评价临床疗效。
①针刺组显效率和治愈率为46.7%(14/30),高于西药组的3.3%(1/30)(<0.01)。针刺组哮喘控制率为66.7%(20/30),高于西药组的13.3%(4/30)(<0.01)。②两组治疗后RDQ评分均低于治疗前(<0.05),针刺组RDQ评分下降幅度大于西药组(<0.05)。两组治疗后ACT评分均高于治疗前(<0.05),针刺组ACT评分升高幅度大于西药组(<0.05)。③针刺组治疗后T至T、T至T棘突下压痛阈值均高于治疗前(<0.05)。西药组治疗后仅T、T、T棘突下压痛阈值高于治疗前(<0.05)。针刺组治疗后T至T棘突下压痛阈值均高于西药组(<0.05)。
通督降逆针法能有效缓解胃食管反流性哮喘症状,提高患者生活质量,疗效优于奥美拉唑肠溶胶囊。